Search for Clinical Trial Results

Sponsored By

Purpura, Thrombocytopenic, Idiopathic - 25 Studies Found

Status Study
Completed Study Name: Pilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP)
Condition: Purpura, Thrombocytopenic, Idiopathic
Date: 2008-06-25
Interventions: Drug: Fostamatinib Disodium / R935788 R935788 tablets
Completed Study Name: Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)
Condition: Purpura, Thrombocytopenic, Idiopathic
Date: 2006-09-06
Interventions:
  • Drug: Rituximab 375mg/m2 per w
Completed Study Name: Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)
Condition: Purpura, Thrombocytopaenic, Idiopathic
Date: 2007-01-17
Interventions: Drug: eltrombopag experimental
Completed Study Name: A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients
Condition: Purpura, Thrombocytopenic, Idiopathic
Date: 2015-03-20
Interventions: Drug: Hetrombopag Olamine Hetrombopag Olamine 2.5mg, 5mg and 7.5mg
Terminated Study Name: Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP).
Condition: Purpura, Thrombocytopenic, Idiopathic
Date: 2013-12-09
Interventions: Drug: BI 655064 subcutaneous injection
Completed Study Name: Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Condition:
  • Chronic Idiopathic Thrombocytopenic Purpura
  • Drug: Placebo Placebo Tablets

Completed Study Name: High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
Condition: Purpura, Thrombocytopenic, Idiopathic
Date: 2011-05-17
Interventions:
  • Drug: Prednisone Prednisone, p
Withdrawn Study Name: A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.
Condition: Purpura, Thrombocytopaenic, Idiopathic
Date: 2011-09-22
Interventions:
  • Drug: Belimumab 10 mg /kg give
Not yet recruiting Study Name: A Single-center Clinical Trial of Bortezomib in Management of Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia
Date: 2016-12-22
Interventions: Drug: Bortezomib Bortezomib was given by intravenous bolus injection at a dose of 1.3 mg/m2 on days 1, 4
Completed Study Name: Daily Prednisone Versus Pulsed Dexamethasone in Treatment-naïve Adult Patients With Immune Thrombocytopenia
Condition: Purpura, Thrombocytopenic, Idiopathic
Date: 2015-01-06
Interventions:
  • Drug: Prednisone
  • Drug: Dexamethasone
Next >>>